Ro60-0175 is a drug of the isotryptamine group developed by Hoffmann–La Roche, which has applications in scientific research.

[1][2] It acts as a potent and selective agonist for both the 5-HT2B and 5-HT2C serotonin receptor subtypes, with good selectivity over the closely related 5-HT2A subtype, and little or no affinity at other receptors.

[3][4] This drug article relating to the nervous system is a stub.

You can help Wikipedia by expanding it.